Related Experiment Video
Updated: Jun 28, 2025
07:17
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
8.1K
[EXPERIENCES OF CONTACT LASER VAPORIZATION OF THE PROSTATE (CVP) FOR TREATING BENIGN PROSTATIC HYPERPLASIA IN THE
Ryo Kitahara1, Shiro Hiragata1, Yuki Matsumoto2
1Hokushin General Hospital.
Summary
Contact laser vaporization of the prostate (CVP) effectively improved symptoms and urinary flow in benign prostatic hyperplasia patients. This treatment was found to be relatively safe, even for elderly individuals and those on antithrombotic medication.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Laser Technology
Context:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Traditional BPH treatments may carry risks for certain patient groups.
- Contact laser vaporization of the prostate (CVP) offers a potential alternative.
Purpose:
- To evaluate the efficacy and safety of CVP for BPH treatment.
- To assess patient outcomes using standardized metrics.
- To determine the feasibility of CVP in specific patient populations.
Summary:
- Forty-five patients with BPH underwent CVP between July 2019 and April 2021.
- Outcomes measured included International Prostate Symptom Score (IPSS), quality of life (QOL) index, peak urinary flow rate (Qmax), and postvoid residual urine volume (PVR).
- Significant improvements in IPSS, QOL, Qmax, and PVR were observed at three months post-procedure (p<0.05).
- Adverse events included meatal strictures, bleeding, and urinary retention, with CVP demonstrating relative safety for elderly patients and those on antithrombotics.
Impact:
- CVP provides a safe and effective treatment option for benign prostatic hyperplasia.
- The procedure shows promise for patients with contraindications to other therapies.
- This study supports the use of CVP in managing BPH in challenging patient cohorts.
